RAG1 and obesity disorder: To investigate the therapeutic potential of targeting adipose ILC1s to improve adipose tissue fibrosis and glycemic intolerance in obesity, IL-12 neutralizing antibody was utilized to block IL-12 signaling activation and subsequent adipose ILC1s accumulation in HFD-fed Rag1−/− mice.